Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021638 220016728 1.87 83 Adjuvant (A) 2018-11-13 2018-12-29 Azacitidine 2 N 220010724 AZACITIDINE
220021639 220004499 1.79 77.8 null 2017-03-16 2017-03-17 DA 3 + 10 N N 220010808 DA
220021640 220004503 null 78.2 Curative (C) 2014-08-24 2014-08-27 DA 3+8 2 N 220010889 DA
220021641 220004509 1.73 77 Palliative (P) 2016-12-21 2018-12-09 Azacitidine N N 220011008 AZACITIDINE
220021642 220004539 1.82 null Curative (C) null 2017-01-25 DA 3+8 02 null 220011747 DA
220021643 220004552 1.24 93.2 Curative (C) 2013-10-28 2013-10-29 Azacitidine Y N 220012142 AZACITIDINE
220021644 220004558 1.53 65 Curative (C) 2018-01-15 2018-01-15 DA Y N 220012148 DA
220021645 220004563 1.6 45.8 null 2015-12-30 2016-02-21 DA 3+8 N N 220012344 DA
220021646 220019223 1.66 71.6 null 2017-04-27 2017-06-13 DA N N 220012451 DA
220021647 220012406 1.72 107 Curative (C) 2016-03-10 2016-03-21 DA 3 + 10 Y N 220012541 DA
220021648 220004583 1.77 86 Curative (C) 2017-05-18 2017-05-18 CYTARABINE + DAUNORUBICIN N N 220012770 DA
220021649 220004586 null 62 null 2015-03-14 2015-03-14 Azacitidine N N 220012814 AZACITIDINE
220021650 220004591 null null null 2017-11-05 2017-11-09 Nilotinib 02 N 220012841 NILOTINIB
220021651 220012419 1.7 null Curative (C) 2016-10-01 2016-10-02 Cytarabine High Dose N N 220012906 CYTARABINE HIGH DOSE
220021652 220004623 0 0 null 2017-05-08 2017-05-08 Nilotinib 2 N 220013701 NILOTINIB
220021653 220004675 null 87.3 Disease modification (D) 2017-12-12 2017-12-12 Nilotinib N N 220015129 NILOTINIB
220021654 220004679 0 0 Curative (C) 2018-06-17 2019-03-26 Nilotinib 2 N 220015258 NILOTINIB
220021655 220004686 1.73 90.1 Curative (C) 2018-06-02 2018-06-05 Cytarabine High Dose 02 N 220015369 CYTARABINE HIGH DOSE
220021658 220004726 0 0 Curative (C) 2014-02-01 2014-08-03 Nilotinib N N 220016177 NILOTINIB
220021663 220004777 0 0 null 2015-02-15 2015-11-27 Nilotinib 02 N 220017427 NILOTINIB
220021664 220012540 1.71 0 Disease modification (D) 2013-02-26 2014-02-26 Nilotinib N N 220018824 NILOTINIB
220021666 220004844 1.56 47.6 Curative (C) 2015-06-16 2015-08-27 Cytarabine High Dose N N 220018973 CYTARABINE HIGH DOSE
220021667 220004851 1.7 null null 2014-11-22 2014-11-22 AML Int Guide HD Cytarabine (3 + 4) 02 N 220019038 CYTARABINE HIGH DOSE
220021668 220004880 1.71 88.6 Curative (C) 2016-10-23 2016-10-23 AML Int Guide HD Cytarabine (3 + 4) 99 N 220019484 CYTARABINE HIGH DOSE
220021669 220012580 1.64 76 Disease modification (D) 2016-06-25 2016-06-25 Nilotinib N N 220019680 NILOTINIB
220021670 220004915 1.68 79 Curative (C) 2013-07-23 2013-07-27 Cytarabine High Dose N null 220019791 CYTARABINE HIGH DOSE
220021671 220004918 1.67 96 Curative (C) 2017-10-09 2017-10-09 Cytarabine High Dose N N 220019796 CYTARABINE HIGH DOSE
220021672 220004922 1.68 62.5 Palliative (P) 2015-12-31 2016-01-15 Cytarabine High Dose 99 N 220019798 CYTARABINE HIGH DOSE
220021673 220004928 1.68 86 Curative (C) null 2014-02-24 AML Int Guide HD Cytarabine (3 + 4) N N 220019810 CYTARABINE HIGH DOSE
220021674 220004958 1.72 null Disease modification (D) 2014-05-05 2016-02-17 Nilotinib 99 N 220019862 NILOTINIB
220021675 220004964 1.73 68.9 Palliative (P) null 2019-02-13 Cytarabine High Dose 99 null 220019873 CYTARABINE HIGH DOSE
220021676 220016894 null null Curative (C) 2016-05-31 2017-05-08 Nilotinib N N 220019888 NILOTINIB
220021677 220004989 null 74.5 Curative (C) 2015-10-24 2015-10-25 Cytarabine High Dose 02 N 220019911 CYTARABINE HIGH DOSE
220021678 220004993 1.8 72 Disease modification (D) 2014-06-12 2014-06-12 AML Int Guide HD Cytarabine (3 + 4) N null 220019932 CYTARABINE HIGH DOSE
220021679 220019303 1.6 82 Curative (C) 2015-01-16 2015-03-19 Cytarabine High Dose 2 null 220019939 CYTARABINE HIGH DOSE
220021680 220005044 1.71 63.9 Curative (C) null 2013-11-24 Cytarabine High Dose 1 N 220020072 CYTARABINE HIGH DOSE
220021681 220012663 1.55 null Disease modification (D) 2016-04-01 2016-04-01 Nilotinib 02 N 220020095 NILOTINIB
220021682 220005061 null 60.2 Palliative (P) null 2017-03-27 AML17 TRIAL 2 N 220020111 AML17 TRIAL
220021683 220005085 1.71 68 Not known (9) 2017-02-08 2017-04-15 FLAG + Idarubicin null null 220020158 FLAG + IDARUBICIN
220021684 220005093 1.04 null Disease modification (D) 2018-04-29 2018-04-29 FLAG + Idarubicin N N 220020160 FLAG + IDARUBICIN
220021685 220005132 1.6 58.5 Curative (C) 2014-08-17 2014-09-28 AML17 TRIAL N N 220020253 AML17 TRIAL
220021686 220005148 1.59 63.8 Curative (C) null 2016-08-24 FLAG + Idarubicin N N 220020290 FLAG + IDARUBICIN
220021687 220005161 0 75 Disease modification (D) 2015-02-02 2015-02-02 FLAG + Idarubicin 02 N 220020301 FLAG + IDARUBICIN
220021688 220005167 1.72 null Curative (C) 2017-07-19 2017-07-25 AML17 TRIAL 02 N 220020318 AML17 TRIAL
220021689 220016965 1.54 84.4 Curative (C) null 2014-12-05 AML17 TRIAL N N 220020360 AML17 TRIAL
220021690 220016972 1.82 72.8 Adjuvant (A) 2014-07-23 2014-12-25 FLAG + Idarubicin 02 N 220020407 FLAG + IDARUBICIN
220021691 220005208 1.57 92.3 Curative (C) 2018-01-23 2018-01-27 AML17 TRIAL 1 N 220020414 AML17 TRIAL
220021692 220005219 1.65 76.3 Curative (C) 2017-03-19 2017-03-22 AML17 TRIAL N N 220020435 AML17 TRIAL
220021693 220005233 null 64.3 Adjuvant (A) 2013-09-17 2016-01-11 AML17 TRIAL 2 null 220020450 AML17 TRIAL
220021696 220005276 1.87 79.6 Curative (C) 2016-06-18 2016-07-21 AML17 TRIAL Y N 220020503 AML17 TRIAL